Deaths of Japanese Patients Prompt Label Change for Simeprevir
The maker of Sovriad (simeprevir) has revised the drug's package insert labeling on the order of Japanese health officials following the deaths of three people who took the hepatitis C drug.
Oncology on Canvas Art Competition Inspires Those Impacted by Cancer
A competition and mural project allow those affected by cancer to express themselves through art.
Hopeful Study Results for Patients with Cirrhosis and Hepatitis C
Patients with cirrhosis who took part in a study that tested a triple combination drug for hepatitis C with ribavirin saw normalization of key laboratory tests after three and six month treatment periods, an indication of improved liver condition.
Could Occupation Help Preserve the Aging Brain?
Jobs requiring intellectually challenging tasks may help preserve thinking skills and memory as workers age, according to a study published online Nov. 19 in Neurology.
Cost of Diabetes Care Keeps Climbing
The cost of diabetes care in the United States has increased 48 percent in recent years, climbing to more than $322 billion annually, according to research published in the December issue of Diabetes Care.
Combining Oncolytic Immunotherapy With Checkpoint Inhibitors Could Affect Cure
Ongoing clinical trials are evaluating a new immunotherapeutic approach for the treatment of malignant melanoma–the combination of an oncolytic virus with checkpoint inhibition.
AMA: Hospital Staff Should Consider Impact of CMS Rule
Hospital medical staff members need to consider the impact of a final rule issued by the Centers for Medicare & Medicaid Services that revised the conditions of participation for hospitals and made two major changes to the hospital governance, according to an article published by the American Medical Association.
Orphan Drug Designation Granted for Ventizumab to Treat Pemphigus
FDA has granted the company’s anti-CD20 antibody, veltuzumab, orphan drug designation to treat patients with pemphigus.
Telephone Reminder Intervention Increases Cardiovascular Prescription Adherence
A low-cost telephone reminder intervention can improve adherence to cardiovascular disease medications, according to a study published online Nov. 16 in the American Journal of Managed Care.